My guest for this episode is Sara Zborovski, a partner at Stikeman Elliott and leader of the firm’s life sciences and healthcare regulatory practice. As we discuss, the recent surge in health sector M&A has shown the importance of expert regulatory guidance relating to everything from telemedicine and medical AI technology to the compliance aspects of roll-up acquisitions of professional practices. Listen and subscribe here: